Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

V114

Bone Therapeutics looks to Pfizer for clinical head

Guy Heynen has 35 years of industry experience

- PMLiVE

Pfizer teams up with snowboarder in meningitis campaign

Amy Purdy won bronze medal at 2014 Paralympic games

- PMLiVE

NICE backs Pfizer drug in kidney cancer

Inlyta near end of two-year struggle for recommendation

Pfizer taps mobile app for patient recruitment

Looks to use smartphone technology to identify rare disease patients

- PMLiVE

ASH: Pfizer eyes re-launch of Mylotarg

Data supports drug's use in acute myeloid leukaemia

- PMLiVE

UPDATE: Merck to acquire Cubist for $8.4bn

Will expand company's presence in antibiotics

- PMLiVE

Pfizer’s CMO joins board of Tenet

Freda Lewis-Hall to advise healthcare services firm

- PMLiVE

Merck files once-weekly DPP-4 inhibitor in first market

Picks Japan to submit omarigliptin

- PMLiVE

Merck buys rights to NewLink’s Ebola vaccine

Drug is set to enter large phase III study in early 2015

- PMLiVE

Pfizer signs $2.85bn immuno-oncology alliance

Will jointly develop Merck KGaA's lead anti-PD-L1 drug

- PMLiVE

Pfizer gets FDA nod for meningitis vaccine Trumenba

Ahead of Novartis’ rival drug Bexsero

- PMLiVE

Merck & Co’s cancer drug Keytruda gaining traction in US

Anti-PD-1 drug is used in around three quarters of eligible patients in US just weeks after FDA approval

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links